Angiotensin receptor‐neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure

Abstract Aims Angiotensin receptor‐neprilysin inhibitor (ARNI) therapy has demonstrated improved outcomes in heart failure with reduced ejection fraction (HFrEF). However, its benefits in patients with concomitant kidney failure undergoing replacement therapy remain uncertain. Methods and results Us...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Mi‐Hyang Jung, Dong‐Hyuk Cho, Jimi Choi, Mi‐Na Kim, Chan Joo Lee, Jung‐Woo Son, Yaeni Kim, Jong‐Chan Youn, Byung‐Su Yoo
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Oxford University Press 2025-10-01
سلاسل:	ESC Heart Failure
الموضوعات:	Heart failure, systolic Hospitalization Kidney failure, chronic Mortality Renin‐angiotensin system Treatment outcome
الوصول للمادة أونلاين:	https://doi.org/10.1002/ehf2.15359
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!